Group 1 - The article does not provide any relevant content regarding company or industry insights [1]

Financial Data and Key Metrics Changes - Group revenue increased by 2.1%, adjusted profit rose by 3.4%, adjusted profit from operations grew by 2.3%, and adjusted diluted EPS was up by 3.4% [8][17] - The company delivered results at the top end of guidance, supported by accelerated momentum through the second half of the year [6][8] - Adjusted operating profit grew by nearly 10%, driven by operating leverage and efficiency gains in combustibles [12] Business Line Data and Key Metrics Changes - New categories revenue grew by 7%, driven by outstanding growth in Modern Oral, which was up strongly by 48%, while Heated Products increased by 1% [8][10] - Combustibles revenue grew by 1%, with volume decline more than offset by a robust price mix across markets [9][10] - Vapor revenue declined by nearly 9%, mainly due to continued illicit pressures in the U.S. and Canada [8][10] Market Data and Key Metrics Changes - In the U.S., combustibles revenue increased by 4.6%, with a value share increase of 30 basis points [10][11] - New category revenue in the U.S. grew nearly 20%, driven by the success of VELO+, which delivered over 300% growth [10][11] - In AME, revenue grew over 3%, with combustibles up more than 2%, supported by strong delivery in Brazil, Turkey, and Mexico [11][12] Company Strategy and Development Direction - The company aims to become a predominantly smokeless business by 2035, focusing on premium innovation and quality growth [20][21] - The Fit to Win program is expected to deliver GBP 600 million of annualized incremental savings by 2028, with a focus on optimizing processes and improving execution [15][16] - The company is committed to reinvesting savings to support further sustainable growth initiatives [15][18] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in returning to the Midterm Algorithm in 2026, with expectations of 3%-5% revenue growth and 4%-6% adjusted profit from operations growth [18][19] - The company is optimistic about the growth potential in Modern Oral and the performance of VELO+ in the U.S. market [22][23] - Management acknowledged challenges in the APMEA region but expects stabilization in performance as regulatory headwinds lessen [13][14] Other Important Information - The company announced an increase in share buyback to GBP 1.3 billion for 2026 and a 2% increase in dividends [3][17] - The company has delivered GBP 1.2 billion in productivity savings since 2023, helping to offset inflationary pressures [15][14] - The company remains on track to generate more than GBP 50 billion in free cash flow by the end of 2030 [18][33] Q&A Session Questions and Answers Question: Expectations for Modern Oral performance in the U.S. for fiscal 2026 - Management believes that the strong retention rate of VELO+ and increasing average daily consumption indicate continued growth potential in the U.S. market [39][40] Question: Factors that could improve performance guidance for 2026 - Management highlighted the potential for improved enforcement in the vapor category and the expected growth in new categories as key factors for better performance [46][49] Question: Insights on heated tobacco share progression in 2026 - Management acknowledged the competitive landscape but expressed confidence in the revamped product offerings, including glo HYLO, to strengthen market position [47][48]

Financial Data and Key Metrics Changes - Group revenue increased by 2.1%, adjusted profit rose by 3.4%, adjusted profit from operations grew by 2.3%, and adjusted diluted EPS was up by 3.4% [8][17] - The company delivered results at the top end of guidance, supported by accelerated momentum through the second half of the year [8][18] - Adjusted profit was impacted by nearly GBP 1.6 billion in amortization related to U.S.-acquired trademarks and a net credit of GBP 524 million from the Canadian combustible industry outlook [6][7] Business Line Data and Key Metrics Changes - New categories revenue grew by 7%, driven by Modern Oral, which was up by 48%, while Heated Products increased by 1% [8][10] - Vapor revenue declined by nearly 9%, primarily due to illicit pressures in the U.S. and Canada [8][10] - Combustible revenue grew by 1%, with volume decline offset by robust price mix across markets [9][10] Market Data and Key Metrics Changes - In the U.S., combustibles revenue increased by 4.6%, with a value share increase of 30 basis points [10][11] - New category revenue in the U.S. grew nearly 20%, driven by VELO+, which delivered over 300% growth [10][11] - In AME, revenue grew over 3%, with combustibles up more than 2%, supported by strong delivery in Brazil, Turkey, and Mexico [11][12] Company Strategy and Development Direction - The company aims to become a predominantly smokeless business by 2035, focusing on premium innovation and quality growth [20][21] - The Fit to Win program is expected to deliver GBP 600 million of annualized incremental savings by 2028, with GBP 500 million expected by 2027 [15][16] - The company is committed to reinvesting savings to support further sustainable growth initiatives [15][18] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in returning to the Midterm Algorithm in 2026, with expectations of 3%-5% revenue growth and 4%-6% adjusted profit from operations growth [18][19] - The company anticipates stabilization in performance in APMEA and continued investment in premium innovations [19][54] - Management highlighted the importance of regulatory improvements and enforcement in the vapor category, which is expected to support future growth [31][32] Other Important Information - The company announced a 2% increase in its dividend and a share buyback increase to GBP 1.3 billion for 2026 [17][18] - The operating margin remained broadly flat at 44%, successfully offsetting inflationary and FX pressures [14][15] - The company has a strong cash generation capability, aiming to deliver more than GBP 50 billion in free cash flow by 2030 [33][34] Q&A Session Summary Question: Expectations for Modern Oral performance in the U.S. for fiscal 2026 - Management believes that the strong retention rate of 70% for VELO+ indicates competitive potential for continued growth in the U.S. market [39][40] Question: Factors that could improve performance in 2026 - Management highlighted the expectation of less drag from Australia and continued investment in premium innovations as key factors for improved performance [45][52] Question: Which category offers the most growth potential - Management expressed that Modern Oral is the most exciting category due to its rapid growth and potential in emerging markets [58][59] Question: Concerns regarding the Australian market - Management acknowledged the challenges in Australia due to increasing illicit market share but noted that the drag will lessen over time [63][64]

Building a Smokeless World Tadeu Marroco – Chief Executive | Javed Iqbal – Interim Chief Financial Officer This presentation does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any BAT shares or other securities. This presentation contains certain forward-looking statements, including "forward-looking" statements made within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements are often, but not always, made through the use ...

Core Viewpoint - British American Tobacco experienced a significant increase in pretax profit driven by the rising demand for vapor and other smokeless products [1] Company Summary - The company reported a notable growth in pretax profit, indicating strong performance in its product segments [1] - The demand for vapor and smokeless products continues to rise, suggesting a shift in consumer preferences towards these alternatives [1] Industry Summary - The overall market for vapor and smokeless products is expanding, reflecting changing trends in the tobacco industry [1] - The growth in this segment may indicate a broader industry shift away from traditional smoking products [1]

Group 1 - European stocks are expected to open higher, with the U.K.'s FTSE index and Germany's DAX projected to rise by 0.4%, France's CAC 40 by 1.1%, and Italy's FTSE MIB by 0.5% [1] - The positive market sentiment follows a mixed closing on Wednesday as investors evaluated a series of corporate earnings reports [2] - A busy earnings day is anticipated, with major companies such as Siemens, L'Oreal, Anheuser-Busch Inbev, British American Tobacco, Mercedes-Benz Group, Adyen, and Deutsche Borse set to report [2] Group 2 - Japan's Nikkei 225 index reached 58,000 for the first time, marking a continuation of its post-election rally [3] - U.S. futures related to the Dow Jones Industrial Average showed little change after the index's three-day winning streak ended [3]

Core Insights - Altria Group, Inc. is focusing on cost discipline to navigate challenges in the U.S. nicotine market, aiming for at least $600 million in cumulative cost savings by the end of 2029 through its "Optimize & Accelerate" initiative [1][8] - The company's adjusted operating companies income (OCI) margin reached 62.4% in 2025, supported by pricing actions and lower settlement charges, despite a 10% decline in domestic cigarette shipment volumes [2][8] - In Q4 2025, adjusted smokeable OCI margins fell to 60.4% due to volume declines and increased promotional spending, indicating emerging strains despite ongoing cost-saving efforts [3][4] Financial Performance - Altria's adjusted OCI margin for smokeable products expanded by 1.8 percentage points to 63.4% for the full year 2025, showcasing resilience against market pressures [2] - The company's shares have increased by 10.3% over the past three months, compared to the industry's growth of 13.3% [7] - Altria's forward price-to-earnings ratio stands at 11.52X, lower than the industry average of 15.83X, indicating potential undervaluation [9] Earnings Estimates - The Zacks Consensus Estimate for Altria's earnings per share for 2026 and 2027 has increased by 1 cent and 6 cents, respectively, to $5.57 and $5.75 [10]

Universal Corporation (NYSE:UVV) is included among the Dividend Champions, Contenders, and Challengers List: 15 Highest Yielding Stocks. Universal Corporation (UVV) Posts Solid Q3 as Tobacco Demand Holds Steady Universal Corporation (NYSE:UVV) reported its fiscal Q3 2026 results on February 9, with Chairman, President, and CEO Preston D. Wigner describing the quarter and the first nine months of the fiscal year as a solid stretch for the company. He said the tobacco business continued to hold up well, su ...

分组1 - The article discusses the author's long-term investment in British American Tobacco (BTI) since 2021, highlighting a personal investment strategy focused on dividend growth and value [1] - The author previously held positions in both Altria (MO) and BTI but has since shifted focus solely to BTI [1] 分组2 - The author has over 10 years of investment experience across various industries, including finance, logistics, oil, and pharmaceuticals, with a strong educational background in accounting and business administration [1]

Core Insights - Philip Morris International Inc. (PMI) will host a live audio webcast presentation at the Consumer Analyst Group of New York (CAGNY) Conference on February 18, 2026, at 10:00 a.m. ET [1] Group 1 - The presentation will feature Jacek Olczak, Group CEO of PMI, and Emmanuel Babeau, Group Chief Financial Officer [1] - The live webcast and presentation slides will be accessible through a provided link [1] - A replay of the webcast will be available for six months following the event [1]